Grindeks to supply oxytocin for PATH's project
This article was originally published in Scrip
Executive Summary
Latvia's Grindeks has entered into a joint project with Instituto Biologico Argentino (BIOL) of Argentina to supply oxytocin for Uniject, BIOL's disposable prefilled syringe. The project is being run by the Program for Appropriate Technology in Health (PATH), an international non-profit organisation, which assists in providing health technologies to developing countries and poor regions. BIOL, a private company that specialises in biological products, has provided the device to PATH since 2004.